Andreas G. Frank Sells 6,000 Shares of Hill-Rom Holdings, Inc. (NYSE:HRC) Stock

Share on StockTwits

Hill-Rom Holdings, Inc. (NYSE:HRC) SVP Andreas G. Frank sold 6,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $105.83, for a total transaction of $634,980.00. Following the completion of the sale, the senior vice president now owns 40,004 shares in the company, valued at $4,233,623.32. The transaction was disclosed in a document filed with the SEC, which is available at this link.

NYSE HRC opened at $106.01 on Wednesday. The company has a market cap of $7.16 billion, a price-to-earnings ratio of 20.87, a price-to-earnings-growth ratio of 1.66 and a beta of 0.82. Hill-Rom Holdings, Inc. has a twelve month low of $81.85 and a twelve month high of $111.63. The company has a quick ratio of 1.10, a current ratio of 1.31 and a debt-to-equity ratio of 1.13. The business’s fifty day moving average is $103.67 and its 200 day moving average is $103.77.

Hill-Rom (NYSE:HRC) last issued its earnings results on Friday, November 1st. The medical technology company reported $1.69 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.65 by $0.04. The business had revenue of $782.80 million during the quarter, compared to analysts’ expectations of $759.14 million. Hill-Rom had a return on equity of 21.67% and a net margin of 5.24%. The business’s revenue for the quarter was up 3.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.63 EPS. On average, research analysts anticipate that Hill-Rom Holdings, Inc. will post 5.52 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 31st. Stockholders of record on Monday, December 16th will be issued a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a dividend yield of 0.79%. The ex-dividend date is Friday, December 13th. Hill-Rom’s dividend payout ratio (DPR) is currently 16.54%.

Several institutional investors have recently added to or reduced their stakes in the company. BB&T Securities LLC acquired a new stake in Hill-Rom during the 2nd quarter worth approximately $322,000. Cubist Systematic Strategies LLC raised its stake in shares of Hill-Rom by 166.5% during the second quarter. Cubist Systematic Strategies LLC now owns 65,660 shares of the medical technology company’s stock valued at $6,869,000 after acquiring an additional 41,025 shares during the last quarter. BlackRock Inc. lifted its holdings in shares of Hill-Rom by 4.9% during the second quarter. BlackRock Inc. now owns 6,649,313 shares of the medical technology company’s stock worth $695,650,000 after purchasing an additional 307,825 shares during the period. Migdal Insurance & Financial Holdings Ltd. lifted its holdings in shares of Hill-Rom by 40.8% during the second quarter. Migdal Insurance & Financial Holdings Ltd. now owns 6,460 shares of the medical technology company’s stock worth $676,000 after purchasing an additional 1,873 shares during the period. Finally, Great Lakes Advisors LLC lifted its holdings in shares of Hill-Rom by 3.5% during the third quarter. Great Lakes Advisors LLC now owns 117,367 shares of the medical technology company’s stock worth $12,351,000 after purchasing an additional 3,965 shares during the period. 82.85% of the stock is owned by institutional investors.

A number of equities analysts recently issued reports on the stock. Barclays upped their price objective on shares of Hill-Rom from $108.00 to $116.00 and gave the stock an “equal weight” rating in a research report on Tuesday, August 6th. Needham & Company LLC restated a “buy” rating and issued a $125.00 target price on shares of Hill-Rom in a research report on Tuesday, August 6th. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Hill-Rom currently has a consensus rating of “Buy” and an average target price of $113.40.

Hill-Rom Company Profile

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

Recommended Story: What causes a stock to be most active?

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.